[논문]Improving potency and metabolic stability by introducing an alkenyl linker to pyridine-based histone deacetylase inhibitors for orally available RUNX3 modulators

Song, Doona; Lee, Chulho; Kook, Yoon Jeong; Oh, Soo Jin; Kang, Jong Soon; Kim, Hyun-Jung; Han, Gyoonhee

doi:10.1016/j.ejmech.2016.11.055

Improving potency and metabolic stability by introducing an alkenyl linker to pyridine-based histone deacetylase inhibitors for orally available RUNX3 modulators

European journal of medicinal chemistry, v.126, 2017년, pp.997 - 1010

Song, Doona (Translational Research Center for Protein Function Control, Department of Biotechnology, Yonsei University, Seoul 120-749, Republic of Korea) , Lee, Chulho (Translational Research Center for Protein Function Control, Department of Biotechnology, Yonsei University, Seoul 120-749, Republic of Korea) , Kook, Yoon Jeong (Translational Research Center for Protein Function Control, Department of Biotechnology, Yonsei University, Seoul 120-749, Republic of Korea) , Oh, Soo Jin (Bioevaluation Center, Korea Research Institute of Bioscience and Biotechnology, Ochang, Cheongwon, Chungbuk 363-883, Republic of Korea) , Kang, Jong Soon (Bioevaluation Center, Korea Research Institute of Bioscience and Biotechnology, Ochang, Cheongwon, Chungbuk 363-883, Republic of Korea) , Kim, Hyun-Jung (Translational Research Center for Protein Function Control, Department of Biotechnology, Yonsei University, Seoul 120-749, Republic of Korea) , Han, Gyoonhee (Translational Research Center for Protein Function Control, Department of Biotechnology, Yonsei University, Seoul 120-749, Republic of Korea)

Abstract ▼ AI-Helper

RUNX3, a tumor suppressor, is suppressed in various cancers by abnormal epigenetic changes. Histone deacetylases (HDACs) can deacetylate the lysine residues of RUNX3, followed by degradation via a ubiquitin-mediated pathway. Inhibition of HDAC leads to functional restoration of the RUNX3 protein by epigenetic expression and RUNX3 protein stabilization. We previously reported a series of HDAC inhibitors that restored RUNX3 function. In the present study, we introduced an alkenyl linker group to pyridine-based HDAC inhibitors to improve their potencies and chemical properties. This alkenyl linker made the compounds more rigid, facilitating a better fit than alkyl moieties to the active site of HDAC proteins. Most compounds in this series exhibited potent RUNX activities, HDAC inhibitory activities, and inhibitory activities towards the growth of human cancer cell lines. Notably, one of these derivatives, (E)-3-(1-cinnamyl-2-oxo-1,2-dihydropyridin-3-yl)-N-hydroxyacrylamide (7k), showed excellent properties in a microsomal stability study, in a xenograft study, and in an in vivo pharmacokinetic evaluation. Modulation of RUNX3 therefore results in highly potent and orally available anticancer chemotherapeutic agents. (C) 2016 Elsevier Masson SAS. All rights reserved.

주제어

참고문헌 (30)

Genes & Dev. Berger 23 781 2009 10.1101/gad.1787609 An operational definition of epigenetics

상세보기
N. Engl. J. Med. Esteller 358 1148 2008 10.1056/NEJMra072067 Epigenetics in cancer

상세보기
Cell Jones 128 683 2007 10.1016/j.cell.2007.01.029 The epigenomics of cancer

상세보기
Nat. Med. Rodriguez-Paredes 17 330 2011 10.1038/nm.2305 Cancer epigenetics reaches mainstream oncology

상세보기
J. Cell. Biochem. Sengupta 93 57 2004 10.1002/jcb.20179 Regulation of histone deacetylase activities

상세보기
Mol. cancer Res. MCR Dokmanovic 5 981 2007 10.1158/1541-7786.MCR-07-0324 Histone deacetylase inhibitors: overview and perspectives

상세보기
Nat. Rev. Drug Discov. Bolden 5 769 2006 10.1038/nrd2133 Anticancer activities of histone deacetylase inhibitors

상세보기
Protein, nucleic acid. enzyme Yoshida 52 1788 2007 [Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A], Tanpakushitsu kakusan koso
Nat. Biotechnol. Marks 25 84 2007 10.1038/nbt1272 Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug

상세보기
Bioorg. Med. Chem. Lett. Belvedere 17 3969 2007 10.1016/j.bmcl.2007.04.089 Aminosuberoyl hydroxamic acids (ASHAs): a potent new class of HDAC inhibitors

상세보기
Drug Resist. Updat. Rev. Comment. Antimicrob. anticancer Chemother. Wilting 15 21 2012 Epigenetic mechanisms in tumorigenesis, tumor cell heterogeneity and drug resistance
Cancer Discov. Popovic 2 405 2012 10.1158/2159-8290.CD-12-0076 Emerging epigenetic targets and therapies in cancer medicine

상세보기
Nat. Rev. Drug Discov. Arrowsmith 11 384 2012 10.1038/nrd3674 Epigenetic protein families: a new frontier for drug discovery

상세보기
Mutat. Res. Holliday 285 61 1993 10.1016/0027-5107(93)90052-H DNA methylation and mutation

상세보기
Cell Li 109 113 2002 10.1016/S0092-8674(02)00690-6 Causal relationship between the loss of RUNX3 expression and gastric cancer

상세보기
Mol. Cell. Biol. Chi 25 8097 2005 10.1128/MCB.25.18.8097-8107.2005 RUNX3 suppresses gastric epithelial cell growth by inducing p21(WAF1/Cip1) expression in cooperation with transforming growth factor {beta}-activated SMAD

상세보기
Oncogene Bae 23 4336 2004 10.1038/sj.onc.1207286 Tumor suppressor activity of RUNX3

상세보기
J. Cell. Biochem. Lee 112 394 2011 10.1002/jcb.22969 Control of RUNX3 by histone methyltransferases

상세보기
J. Biol. Chem. Jin 279 29409 2004 10.1074/jbc.M313120200 Transforming growth factor-beta stimulates p300-dependent RUNX3 acetylation, which inhibits ubiquitination-mediated degradation

상세보기
Am. J. Transl. Res. Kim 3 166 2011 Histone deacetylase inhibitors: molecular mechanisms of action and clinical trials as anti-cancer drugs

상세보기
ChemMedChem Cho 9 649 2014 10.1002/cmdc.201300393 Lactam-based HDAC inhibitors for anticancer chemotherapy: restoration of RUNX3 by posttranslational modification and epigenetic control

상세보기
ChemMedChem Cho 8 272 2013 10.1002/cmdc.201200529 Discovery of pyridone-based histone deacetylase inhibitors: approaches for metabolic stability

상세보기
J. Med. Chem. Kim 50 2737 2007 10.1021/jm0613828 Structure-activity relationship studies of a series of novel delta-lactam-based histone deacetylase inhibitors

상세보기
J. Cell. Biochem. Kim 91 1239 2004 10.1002/jcb.20038 Establishment and characterization of a stable cell line to evaluate cellular Runx2 activity

상세보기
Biochem. biophysical Res. Commun. Li 314 223 2004 10.1016/j.bbrc.2003.12.079 Transcriptional silencing of the RUNX3 gene by CpG hypermethylation is associated with lung cancer

상세보기
Nucleic acids Res. Dignam 11 1475 1983 10.1093/nar/11.5.1475 Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei

상세보기
J. Natl. Cancer Inst. Skehan 82 1107 1990 10.1093/jnci/82.13.1107 New colorimetric cytotoxicity assay for anticancer-drug screening

상세보기
Xenobiotica; fate foreign Compd. Biol. Syst. Lee 39 255 2009 10.1080/00498250802650069 Plasma pharmacokinetics and metabolism of the antitumour drug candidate 2'-benzoyloxycinnamaldehyde in rats

상세보기
J. Med. Chem. Choi 55 10766 2012 10.1021/jm3009376 Property-based optimization of hydroxamate-based gamma-lactam HDAC inhibitors to improve their metabolic stability and pharmacokinetic profiles

상세보기
J. Med. Chem. Yang 58 3512 2015 10.1021/acs.jmedchem.5b00062 Discovery of orally available runt-related transcription factor 3 (RUNX3) modulators for anticancer chemotherapy by epigenetic activation and protein stabilization

상세보기

LOADING...

내보내기 구분	파일저장 인쇄 메일전송
구성항목	기본정보 상세정보 관리번호, 논문명, 저널/프로시딩명, 저자 , 발행년, 권, 호, 시작페이지, 끝페이지, 발행기관 관리번호, 논문명, 대등논문명, 저자 , 저널/프로시딩명, 발행기관, 발행년, 발행언어, 권, 호, 시작페이지, 끝페이지, ISBN, ISSN, 주제분야, 키워드, 초록(한글), 초록(영문), 저자(소속기관)
저장형식	Text(ASCII format) Excel format RefWorks Direct Export RIS format (for Reference Manager, ProCite, EndNote), Scholar's Aids, Mendeley
메일정보	받는사람 (필수) @ 보내는사람 (선택) @ 제목 내용 KISTI 검색결과 이메일 서비스
안내	총 건의 자료가 검색되었습니다. 다운받으실 자료의 인덱스를 입력하세요. (1-10,000) 검색결과의 순서대로 최대 10,000건 까지 다운로드가 가능합니다. 데이타가 많을 경우 속도가 느려질 수 있습니다.(최대 2~3분 소요) 다운로드 파일은 UTF-8 형태로 저장됩니다. 파일의 내용이 제대로 보이지 않을실 때는 웹브라우저 상단의 보기 -> 인코딩 -> 자동선택 여부를 확인하십시오. ~ Text(ASCII format) Excel format

연합인증

Improving potency and metabolic stability by introducing an alkenyl linker to pyridine-based histone deacetylase inhibitors for orally available RUNX3 modulators

Abstract ▼ AI-Helper

주제어

참고문헌 (30)

이 논문을 인용한 문헌

연구과제 타임라인

관련 콘텐츠

원문 URL 링크

이 논문과 함께 이용한 콘텐츠

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

선택된 텍스트

연합인증

Improving potency and metabolic stability by introducing an alkenyl linker to pyridine-based histone deacetylase inhibitors for orally available RUNX3 modulators

Abstract ▼ AI-Helper

주제어

참고문헌 (30)

이 논문을 인용한 문헌

연구과제 타임라인

전체(0) 논문(0) 특허(0) 보고서(0)

전체(0) 논문(0) 특허(0) 보고서(0)

관련 콘텐츠

원문 URL 링크

이 논문과 함께 이용한 콘텐츠

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

선택된 텍스트